ストックスクリーナーアプリを入手
3.04
2.36%
0.07
アフターアワーズ：
3.03
-0.01
-0.33%
前日終値:
$2.97
開ける：
$2.93
24時間の取引高:
1.52M
Relative Volume:
0.53
時価総額：
$292.65M
収益：
-
当期純損益:
$-158.52M
株価収益率:
-1.2033
EPS:
-2.5263
ネットキャッシュフロー:
$-120.26M
1週間 パフォーマンス:
-4.70%
1か月 パフォーマンス:
-3.18%
6か月 パフォーマンス:
+38.81%
1年 パフォーマンス:
+70.79%
1日の値動き範囲:
$2.86
$3.10
1週間の範囲:
$2.84
$3.2799
52週間の値動き範囲:
$0.9857
$3.78
Cabaletta Bio Inc Stock (CABA) Company Profile
Compare CABA vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CABA
Cabaletta Bio Inc
|
3.04 | 285.91M | 0 | -158.52M | -120.26M | -2.5263 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-10 | 再開されました | Jefferies | Buy |
| 2024-12-20 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2024-12-19 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-10-10 | 開始されました | UBS | Buy |
| 2024-02-05 | 開始されました | Jefferies | Buy |
| 2023-11-29 | 開始されました | William Blair | Outperform |
| 2023-10-24 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-10-19 | 開始されました | Stifel | Buy |
| 2023-09-05 | 開始されました | Citigroup | Buy |
| 2023-07-18 | 開始されました | Guggenheim | Buy |
| 2023-01-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-08-30 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-08 | 開始されました | Wells Fargo | Overweight |
| 2021-10-19 | 再開されました | Morgan Stanley | Overweight |
| 2021-06-30 | 開始されました | Mizuho | Buy |
| 2021-01-08 | 開始されました | Chardan Capital Markets | Buy |
| 2020-10-13 | 開始されました | H.C. Wainwright | Buy |
| 2019-11-19 | 開始されました | Cowen | Outperform |
| 2019-11-19 | 開始されました | Evercore ISI | Outperform |
| 2019-11-19 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Cabaletta Bio Inc (CABA) 最新ニュース
Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Heights Capital Management Inc. Sells 1,059,904 Shares of Cabaletta Bio, Inc. $CABA - MarketBeat
Merger Talk: Will Cabaletta Bio Inc announce a stock splitInflation Watch & Long-Term Safe Return Strategies - baoquankhu1.vn
Quarterly Earnings: Will Bowman Consulting Group Ltd benefit from seasonality2026 Top Gainers & Weekly Breakout Watchlists - baoquankhu1.vn
What are Cabaletta Bio Incs recent SEC filings showingWeekly Risk Report & Breakout Confirmation Trade Signals - baoquankhu1.vn
Cabaletta Bio Reports Promising Data from RESET Trials for Transformative Autoimmune Therapy - MSN
Cabaletta Bio (CABA) upgraded to buy: Here's what you should know - MSN
Cabaletta Bio Highlights Pivotal Myositis Trial, No-Preconditioning CAR-T Push at TD Cowen Conference - MarketBeat
Day Trade: What are Cabaletta Bio Inc.’s recent SEC filings showingJuly 2025 Sector Moves & Free Reliable Trade Execution Plans - baoquankhu1.vn
Aug Sectors: Is Cabaletta Bio Incs ROE strong enough2025 Analyst Calls & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Cabaletta Bio takes spotlight at Guggenheim Summit as autoimmune bet advances - MSN
Cabaletta Bio (CABA) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Cabaletta Bio (CABA) to Release Quarterly Earnings on Thursday - MarketBeat
CABA SEC FilingsCabaletta Bio, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
TD Cowen Health Care Conference - marketscreener.com
Are healthcare stocks underperforming Biodesix (BDSX) so far this year? - Bitget
Are Medical Stocks Lagging Biodesix (BDSX) This Year? - Yahoo Finance
[Form 4] Cabaletta Bio, Inc. Insider Trading Activity - Stock Titan
Cabaletta Bio (CABA) grants 175,000 stock options to General Counsel - Stock Titan
Cabaletta Bio (CABA) CFO awarded 225,000-share stock option grant - Stock Titan
Gains Report: Can Cabaletta Bio Inc deliver consistent dividendsJuly 2025 Analyst Calls & Fast Gain Swing Alerts - baoquankhu1.vn
CABA Should I Buy - Intellectia AI
CABA Technical Analysis & ETF Price Forecast - Intellectia AI
Here’s why Jacob Funds established a position in Cabaletta Bio (CABA) - MSN
Millennium Management LLC's Strategic Acquisition of Cabaletta B - GuruFocus
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference - The Manila Times
Short Covering: Will Cabaletta Bio Inc announce a stock split2025 Price Targets & Scalable Portfolio Growth Methods - baoquankhu1.vn
Aug EndMonth: What drives SATLWs stock price2025 Market Sentiment & Stock Market Timing Techniques - baoquankhu1.vn
Dividend Watch: Is PECO stock a falling knife or bargain buyRisk Management & Growth Oriented Trade Recommendations - baoquankhu1.vn
CABA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cabaletta Bio, Inc. (NASDAQ:CABA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Market Rankings: Is Cabaletta Bio Inc stock trending bullishJuly 2025 Analyst Calls & High Accuracy Swing Trade Signals - baoquankhu1.vn
Millennium Group (CABA) jointly reports 5.3% holding of 5.13M shares - Stock Titan
Aug Shorts: Does Cabaletta Bio Inc have strong EBITDA marginsJuly 2025 Update & Accurate Buy Signal Notifications - baoquankhu1.vn
Here’s Why Jacob Funds Established a Position in Cabaletta Bio (CABA) - Insider Monkey
Alyeska group reports 4.67% Cabaletta Bio (CABA) stake via 4.5M warrants - Stock Titan
What are Cabaletta Bio Inc.’s recent SEC filings showingPortfolio Update Summary & Daily Risk Controlled Trade Plans - mfd.ru
CABA News & Events - Intellectia AI
Best Swing Trade Stocks Right Now • Updated Daily - Benzinga
Pharma News: Why retail investors favor Cabaletta Bio Inc. stock2025 Historical Comparison & Fast Entry High Yield Tips - mfd.ru
Cabaletta Bio Kicks Off Pivotal Myositis Trial, Touts Automated CAR-T Manufacturing Path to 2027 BLA - MarketBeat
Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year? - Nasdaq
Aug Drivers: Is Cabaletta Bio Inc stock a smart retirement pickJuly 2025 Recap & Fast Moving Market Watchlists - baoquankhu1.vn
CABA News Today | Why did Cabaletta Bio stock go up today? - MarketBeat
Cabaletta Bio Takes Spotlight at Guggenheim Summit as Autoimmune Bet Advances - MyChesCo
Cabaletta Bio shares climb after insider purchases - MSN
Update Recap: Is Cabaletta Bio Inc stock overvalued or fairly priced2025 Macro Impact & AI Powered Market Entry Strategies - baoquankhu1.vn
Trend Review: Is Cabaletta Bio Inc stock overvalued or fairly pricedJuly 2025 Technicals & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Cabaletta Bio (CABA) and Ocular Therapeutix (OCUL) - The Globe and Mail
Cabaletta Bio to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026 - Quiver Quantitative
Cabaletta Bio Inc (CABA) 財務データ
収益
当期純利益
現金流量
EPS
1.20%
0.06%
大文字化:
|
ボリューム (24 時間):